Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Pentobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.46 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.46 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 7/20 | 0.38 |
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentobarbital SCHEMBL3032837 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL3032984 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL3030042 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Stearic Acid SCHEMBL8022452 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL22265808 | 0.94 | CYP3A4 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL9770106 | 0.93 | CYP3A4 (0.46) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL3474760 | 0.92 | CYP3A4 (0.48) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL22091797 | 0.91 | CYP3A4 (0.44) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL16240950 | 0.91 | CYP3A4 (0.47) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 | |
| Pentobarbital SCHEMBL22091750 | 0.90 | CYP3A4 (0.42) | ALDH1A1CYP3A4KDM4EGABRB3OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100215603-A1 | Body Surface Protecting Composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1891924-A1 | COMPOSITION FOR PROTECTION OF BODY SURFACE | Asahi Kasei Chemicals Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215603-A1 | Body Surface Protecting Composition | FABP2, CUTA, FABP1 | GABRB3 1278/4885GABRA2 2048/4885GABRB2 1266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.